Please note: this is a draft programme and therefore subject to change.

Day 1 – Tuesday 21st April: 12:00 – 18:20

12:00                Lunch
14:00                Welcome - Professor Robert Ali

The pharmacology of opioid safety - Prof. Sharon Walsh
Treating HIV in the context of opioid dependence - Prof. Elinore McCance-Katz
Assessing the risks of benzodiazepines in opioid pharmacotherapy - Prof. Nicholas Lintzeris
Hidden risks: cardiac safety in opioid maintenance therapy - Prof. Mori Krantz
Drug–drug interactions in opioid dependence - Panel Discussion

SESSION 2: MANAGING THE UNEXPECTED: ACUTE THREATS TO PATIENT STABILITY

Revolving doors: at the interface between criminal justice and treatment services - Dr Heino Stöver
Managing acute pain in opioid dependence - Prof. Walter Ling
Pregnancy and opioid dependence - Prof. Laurent Gourarier
Ethics in opioid pharmacotherapy: are we doing all we can to maximise safety? - Panel Discussion and Workshop

Day 2 – Wednesday 22nd April: 08:45 – 17:15

Panel discussion

SESSION 3: MAXIMISING ACCESS: MINIMISING RISKS

French solution for global export? - Prof. Marc Auriacombe
Buprenorphine diversion in France: not as it appears - Dr Pascal Courty
Office-based prescribing: the US story - Dr David Fiellin
Beyond the office: widening maintenance access through harm reduction services - Dr Sharon Stancliff
Examining the abuse liability of maintenance medications for opioid dependence - Prof. Sandra Comer
Increasing treatment access in Australia - Prof. Robert Ali
Maximising access: a tale of morality, politics and pharmacology - Prof. Nicholas Lintzeris
Maximising access and minimising risks - Panel Discussion

Splitting hairs: chronic pain, analgesic addiction and pharmacotherapy - Dr Steven Passik
Serious psychiatric comorbidities in opioid dependence - Dr Neville Wright
Managing opioid dependence in the context of mood disorders - Dr Michael Farrell
HIV and HCV in an opioid-dependent patient - Dr Stephan Walcher
Complex case study clinic - Panel Discussion

Day 3 –Thursday 23rd April: 08:40 – 13:45

Panel discussion

SESSION 5: CRITICAL DIFFERENCES IN THE CLINICAL CONTEXT

Critical differences in pharmacology - Prof. Sharon Walsh
How to transition safely between opioids - Prof. Nicholas Lintzeris
Treating him, treating her: ORT and gender - Prof. Gabriele Fischer
Fundamental differences: the treatment experience - Prof. Miriam Mintzer
Taking the next step: evidence-based approaches to managed opioid withdrawal - Prof. Robert Ali
The STEP model - Dr Johan Kakko
Best practice in treatment selection - Panel Discussion